RESEARCH

The Cellu M6 Keymodule for Lipomassage is a technology developed by LPG, founded by Louis Paul Guitay. The first version of this revolutionary machine was introduced to the world in 1986. Since that time, LPG has conducted extensive research to find the highest and best use for this technology. The latest model of the Cellu M6 adjusts intelligently for more rapid results and comfortable application.

To read more about LPG and their research, click here.

Erchonia LipoLASER was the first and only Low Level Laser given FDA clearance. Through years of research and refinement the EML LipoLASER has become an indispensable tool used by endermologie therapists, physicians, and surgeons in many of areas. Erchonia’s Cold Laser is different than conventional lasers in that it does not generate heat or thermal output which has the power to destroy tissue. Rather, the Erchonia Laser produces a low-level (or cold) output that serves to stimulate biological function. Many blind studies have been done to determine the effectiveness of low-level laser therapy in decreasing liposuction patients degree of postoperative discomfort, reducing swelling, enhancing wound healing, facilitating fat extraction for surgeon, and enhancing the emulsification of fat (for references see The American Journal of  Cosmetic Surgery Vol. 21, No 4, 2004).

To read more about Erchonia and their research, click here.